AccutarBio
About:
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Website: https://www.accutarbio.com
Top Investors: ZhenFund, IDG Capital, Yitu Technology
Description:
AccutarBio employs artificial intelligence to revolutionize drug discovery. AccutarBio's philosophy is to derive a data-driven principle that has the power of explaining physical and chemical nature of biological systems, which we harness to accelerate drug discoveries.
Total Funding Amount:
$76.6M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2015-01-01
Founders:
Jie Fan, Ke Liu
Number of Employees:
11-50
Last Funding Date:
2021-01-05
IPO Status:
Private
© 2024 MyAiNote.com